Product
Rabies
1 clinical trial
1 indication
Indication
ShigellosisClinical trial
Safety and Immunogenicity of a Shigella-Tetravalent Bioconjugate Vaccine: A Phase 1/2 Randomized Controlled and Age Descending Study Including Dose Finding in 9 Month Old InfantsStatus: Completed, Estimated PCD: 2022-09-01